Work

A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.2518

Authors: Baukelien Van Triest, Lars Damstrup, Johan Falkenius, Volker Budach, Esther Troost, Michael Samuels, Juergen Debus, Morten Mau Sørensen, Karin Berghoff, Rainer Strotman, Mark van Bussel, Sanjay Goel, Poul F. Geertsen

Institutions: The Netherlands Cancer Institute, Merck KGaA, Darmstadt (Germany), Karolinska Institutet, Charité – Universitätsmedizin Berlin, University Hospital Carl Gustav Carus, Technische Universität Dresden, University of Miami, Sylvester Comprehensive Cancer Center, University Hospital Heidelberg, Rigshospitalet, Albert Einstein College of Medicine, Montefiore Medical Center, University of Copenhagen, Herlev Hospital

Language: English

Topic: Effects of Radiation Exposure

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890440076

Cites:

Cited by: 19

Related to: 10